HEADER MEMBRANE PROTEIN 06-FEB-12 4DLD TITLE CRYSTAL STRUCTURE OF THE GLUK1 LIGAND-BINDING DOMAIN (S1S2) IN COMPLEX TITLE 2 WITH THE ANTAGONIST (S)-2-AMINO-3-(2-(2-CARBOXYETHYL)-5-CHLORO-4- TITLE 3 NITROPHENYL)PROPIONIC ACID AT 2.0 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RECEPTOR, IONOTROPIC KAINATE 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: GLUK1 LIGAND BINDING DOMAIN (GLUK1-S1S2); COMPND 5 SYNONYM: GLUTAMATE RECEPTOR 5, GLUR-5, GLUR5; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: THE PROTEIN CRYSTALLIZED IS THE EXTRACELLULAR LIGAND COMPND 8 BINDING DOMAIN OF GLUK1. TRANSMEMBRANE REGIONS WERE GENETICALLY COMPND 9 REMOVED AND REPLACED WITH A GLY-THR LINKER. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: GRIK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ORIGAMI 2; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS IONOTROPIC GLUTAMATE RECEPTOR, GLUTAMATE, MEMBRANE, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.VENSKUTONYTE,K.FRYDENVANG,J.S.KASTRUP REVDAT 4 30-OCT-24 4DLD 1 REMARK REVDAT 3 08-NOV-23 4DLD 1 REMARK SEQADV REVDAT 2 16-AUG-17 4DLD 1 SOURCE REMARK REVDAT 1 10-OCT-12 4DLD 0 JRNL AUTH R.VENSKUTONYTE,K.FRYDENVANG,E.A.VALADES,E.SZYMANSKA, JRNL AUTH 2 T.N.JOHANSEN,J.S.KASTRUP,D.S.PICKERING JRNL TITL STRUCTURAL AND PHARMACOLOGICAL CHARACTERIZATION OF JRNL TITL 2 PHENYLALANINE-BASED AMPA RECEPTOR ANTAGONISTS AT KAINATE JRNL TITL 3 RECEPTORS JRNL REF CHEMMEDCHEM V. 7 1793 2012 JRNL REFN ISSN 1860-7179 JRNL PMID 22407805 JRNL DOI 10.1002/CMDC.201100599 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.NAUR,B.VESTERGAARD,L.K.SKOV,J.EGEBJERG,M.GAJHEDE, REMARK 1 AUTH 2 J.S.KASTRUP REMARK 1 TITL CRYSTAL STRUCTURE OF THE KAINATE RECEPTOR GLUR5 REMARK 1 TITL 2 LIGAND-BINDING CORE IN COMPLEX WITH (S)-GLUTAMATE. REMARK 1 REF FEBS LETT. V. 579 1154 2005 REMARK 1 REFN ISSN 0014-5793 REMARK 1 PMID 15710405 REMARK 1 DOI 10.1016/J.FEBSLET.2005.01.012 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.7.1_743 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.88 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 39768 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.020 REMARK 3 FREE R VALUE TEST SET COUNT : 1997 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 25.8796 - 4.8108 0.98 2929 145 0.1907 0.2200 REMARK 3 2 4.8108 - 3.8224 1.00 2757 163 0.1507 0.2020 REMARK 3 3 3.8224 - 3.3404 1.00 2726 157 0.1774 0.2503 REMARK 3 4 3.3404 - 3.0355 1.00 2700 145 0.1878 0.2369 REMARK 3 5 3.0355 - 2.8182 1.00 2723 123 0.1980 0.2475 REMARK 3 6 2.8182 - 2.6522 1.00 2685 133 0.2050 0.2661 REMARK 3 7 2.6522 - 2.5195 1.00 2684 160 0.1975 0.2801 REMARK 3 8 2.5195 - 2.4099 1.00 2646 152 0.1995 0.2806 REMARK 3 9 2.4099 - 2.3172 1.00 2639 157 0.1952 0.2750 REMARK 3 10 2.3172 - 2.2373 1.00 2671 109 0.1920 0.2561 REMARK 3 11 2.2373 - 2.1674 1.00 2671 127 0.1804 0.2427 REMARK 3 12 2.1674 - 2.1054 1.00 2662 145 0.1953 0.2654 REMARK 3 13 2.1054 - 2.0500 1.00 2622 142 0.2016 0.2790 REMARK 3 14 2.0500 - 2.0000 1.00 2656 139 0.2213 0.2943 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.00 REMARK 3 SHRINKAGE RADIUS : 0.72 REMARK 3 K_SOL : 0.35 REMARK 3 B_SOL : 40.27 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.570 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.610 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.09 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.61 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.01900 REMARK 3 B22 (A**2) : 2.01900 REMARK 3 B33 (A**2) : -4.03800 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4252 REMARK 3 ANGLE : 1.035 5744 REMARK 3 CHIRALITY : 0.069 629 REMARK 3 PLANARITY : 0.005 727 REMARK 3 DIHEDRAL : 14.384 1632 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4DLD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 10-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1000070474. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I911-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0380 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.9 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 39813 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 25.877 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08100 REMARK 200 FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 8.00 REMARK 200 R MERGE FOR SHELL (I) : 0.31800 REMARK 200 R SYM FOR SHELL (I) : 0.31800 REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2PBW CHAIN A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.42 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17 % PEG4000, 0.1M CACODYLIC ACID, REMARK 280 0.3M LITHIUM SULFATE, PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 279K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 117.48500 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 34.66000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 34.66000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 58.74250 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 34.66000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 34.66000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 176.22750 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 34.66000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 34.66000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 58.74250 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 34.66000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 34.66000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 176.22750 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 117.48500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1 REMARK 465 ALA A 2 REMARK 465 GLY B 1 REMARK 465 ALA B 2 REMARK 465 ASN B 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 13 109.46 -161.37 REMARK 500 ASP A 139 16.61 54.28 REMARK 500 GLU B 13 110.78 -164.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TZG A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TZG B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3TZA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GLUA2 LIGAND BINDING DOMAIN IN COMPLEX REMARK 900 WITH AN ANTAGONIST (S)-2-AMINO-3-(2-(2-CARBOXYETHYL)-5-CHLORO-4- REMARK 900 NITROPHENYL)PROPIONIC ACID REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE DATABASE IS P22756-2, ISOFORM GLUR5-2. REMARK 999 THE CRYSTALLIZED PROTEIN CONSISTS OF GLY RESIDUE FOLLOWED REMARK 999 BY RESIDUE 430-544 AND 667-805 FROM THE INTACT RECEPTOR REMARK 999 LINKED BY A GLY-THR DIPEPTIDE. THERE IS A SEQUENCE REMARK 999 CONFLICT AT RESIDUE 34 OF THE CRYSTALLIZED PROTEIN DUE TO REMARK 999 DIFFERENCES IN DATABASE SEQUENCE REMARK 999 (SEE GENBANK ACCESION NO.AAA02874). DBREF 4DLD A 2 116 UNP P22756 GRIK1_RAT 430 544 DBREF 4DLD A 119 257 UNP P22756 GRIK1_RAT 667 805 DBREF 4DLD B 2 116 UNP P22756 GRIK1_RAT 430 544 DBREF 4DLD B 119 257 UNP P22756 GRIK1_RAT 667 805 SEQADV 4DLD GLY A 1 UNP P22756 EXPRESSION TAG SEQADV 4DLD GLY A 34 UNP P22756 ALA 462 SEE REMARK 999 SEQADV 4DLD GLY A 117 UNP P22756 LINKER SEQADV 4DLD THR A 118 UNP P22756 LINKER SEQADV 4DLD GLY B 1 UNP P22756 EXPRESSION TAG SEQADV 4DLD GLY B 34 UNP P22756 ALA 462 SEE REMARK 999 SEQADV 4DLD GLY B 117 UNP P22756 LINKER SEQADV 4DLD THR B 118 UNP P22756 LINKER SEQRES 1 A 257 GLY ALA ASN ARG THR LEU ILE VAL THR THR ILE LEU GLU SEQRES 2 A 257 GLU PRO TYR VAL MET TYR ARG LYS SER ASP LYS PRO LEU SEQRES 3 A 257 TYR GLY ASN ASP ARG PHE GLU GLY TYR CYS LEU ASP LEU SEQRES 4 A 257 LEU LYS GLU LEU SER ASN ILE LEU GLY PHE LEU TYR ASP SEQRES 5 A 257 VAL LYS LEU VAL PRO ASP GLY LYS TYR GLY ALA GLN ASN SEQRES 6 A 257 ASP LYS GLY GLU TRP ASN GLY MET VAL LYS GLU LEU ILE SEQRES 7 A 257 ASP HIS ARG ALA ASP LEU ALA VAL ALA PRO LEU THR ILE SEQRES 8 A 257 THR TYR VAL ARG GLU LYS VAL ILE ASP PHE SER LYS PRO SEQRES 9 A 257 PHE MET THR LEU GLY ILE SER ILE LEU TYR ARG LYS GLY SEQRES 10 A 257 THR PRO ILE ASP SER ALA ASP ASP LEU ALA LYS GLN THR SEQRES 11 A 257 LYS ILE GLU TYR GLY ALA VAL ARG ASP GLY SER THR MET SEQRES 12 A 257 THR PHE PHE LYS LYS SER LYS ILE SER THR TYR GLU LYS SEQRES 13 A 257 MET TRP ALA PHE MET SER SER ARG GLN GLN SER ALA LEU SEQRES 14 A 257 VAL LYS ASN SER ASP GLU GLY ILE GLN ARG VAL LEU THR SEQRES 15 A 257 THR ASP TYR ALA LEU LEU MET GLU SER THR SER ILE GLU SEQRES 16 A 257 TYR VAL THR GLN ARG ASN CYS ASN LEU THR GLN ILE GLY SEQRES 17 A 257 GLY LEU ILE ASP SER LYS GLY TYR GLY VAL GLY THR PRO SEQRES 18 A 257 ILE GLY SER PRO TYR ARG ASP LYS ILE THR ILE ALA ILE SEQRES 19 A 257 LEU GLN LEU GLN GLU GLU GLY LYS LEU HIS MET MET LYS SEQRES 20 A 257 GLU LYS TRP TRP ARG GLY ASN GLY CYS PRO SEQRES 1 B 257 GLY ALA ASN ARG THR LEU ILE VAL THR THR ILE LEU GLU SEQRES 2 B 257 GLU PRO TYR VAL MET TYR ARG LYS SER ASP LYS PRO LEU SEQRES 3 B 257 TYR GLY ASN ASP ARG PHE GLU GLY TYR CYS LEU ASP LEU SEQRES 4 B 257 LEU LYS GLU LEU SER ASN ILE LEU GLY PHE LEU TYR ASP SEQRES 5 B 257 VAL LYS LEU VAL PRO ASP GLY LYS TYR GLY ALA GLN ASN SEQRES 6 B 257 ASP LYS GLY GLU TRP ASN GLY MET VAL LYS GLU LEU ILE SEQRES 7 B 257 ASP HIS ARG ALA ASP LEU ALA VAL ALA PRO LEU THR ILE SEQRES 8 B 257 THR TYR VAL ARG GLU LYS VAL ILE ASP PHE SER LYS PRO SEQRES 9 B 257 PHE MET THR LEU GLY ILE SER ILE LEU TYR ARG LYS GLY SEQRES 10 B 257 THR PRO ILE ASP SER ALA ASP ASP LEU ALA LYS GLN THR SEQRES 11 B 257 LYS ILE GLU TYR GLY ALA VAL ARG ASP GLY SER THR MET SEQRES 12 B 257 THR PHE PHE LYS LYS SER LYS ILE SER THR TYR GLU LYS SEQRES 13 B 257 MET TRP ALA PHE MET SER SER ARG GLN GLN SER ALA LEU SEQRES 14 B 257 VAL LYS ASN SER ASP GLU GLY ILE GLN ARG VAL LEU THR SEQRES 15 B 257 THR ASP TYR ALA LEU LEU MET GLU SER THR SER ILE GLU SEQRES 16 B 257 TYR VAL THR GLN ARG ASN CYS ASN LEU THR GLN ILE GLY SEQRES 17 B 257 GLY LEU ILE ASP SER LYS GLY TYR GLY VAL GLY THR PRO SEQRES 18 B 257 ILE GLY SER PRO TYR ARG ASP LYS ILE THR ILE ALA ILE SEQRES 19 B 257 LEU GLN LEU GLN GLU GLU GLY LYS LEU HIS MET MET LYS SEQRES 20 B 257 GLU LYS TRP TRP ARG GLY ASN GLY CYS PRO HET TZG A 301 21 HET CL A 302 1 HET TZG B 301 21 HET SO4 B 302 5 HET GOL B 303 6 HETNAM TZG (S)-2-AMINO-3-(2-(2-CARBOXYETHYL)-5-CHLORO-4- HETNAM 2 TZG NITROPHENYL)PROPIONIC ACID HETNAM CL CHLORIDE ION HETNAM SO4 SULFATE ION HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 TZG 2(C12 H13 CL N2 O6) FORMUL 4 CL CL 1- FORMUL 6 SO4 O4 S 2- FORMUL 7 GOL C3 H8 O3 FORMUL 8 HOH *501(H2 O) HELIX 1 1 TYR A 27 ASP A 30 5 4 HELIX 2 2 GLY A 34 GLY A 48 1 15 HELIX 3 3 ASN A 71 ASP A 79 1 9 HELIX 4 4 THR A 92 LYS A 97 1 6 HELIX 5 5 SER A 122 LYS A 128 1 7 HELIX 6 6 GLY A 140 SER A 149 1 10 HELIX 7 7 ILE A 151 SER A 167 1 17 HELIX 8 8 ASN A 172 THR A 183 1 12 HELIX 9 9 SER A 191 GLN A 199 1 9 HELIX 10 10 PRO A 225 GLU A 240 1 16 HELIX 11 11 GLY A 241 ARG A 252 1 12 HELIX 12 12 TYR B 27 ASP B 30 5 4 HELIX 13 13 GLY B 34 GLY B 48 1 15 HELIX 14 14 ASN B 71 ASP B 79 1 9 HELIX 15 15 THR B 92 LYS B 97 1 6 HELIX 16 16 SER B 122 LYS B 128 1 7 HELIX 17 17 GLY B 140 SER B 149 1 10 HELIX 18 18 ILE B 151 SER B 167 1 17 HELIX 19 19 ASN B 172 THR B 183 1 12 HELIX 20 20 SER B 191 GLN B 199 1 9 HELIX 21 21 TYR B 226 GLU B 240 1 15 HELIX 22 22 GLY B 241 ARG B 252 1 12 SHEET 1 A 3 TYR A 51 LEU A 55 0 SHEET 2 A 3 LEU A 6 THR A 10 1 N VAL A 8 O LYS A 54 SHEET 3 A 3 LEU A 84 ALA A 85 1 O LEU A 84 N THR A 9 SHEET 1 B 2 MET A 18 TYR A 19 0 SHEET 2 B 2 PHE A 32 GLU A 33 -1 O GLU A 33 N MET A 18 SHEET 1 C 2 ASP A 100 PHE A 101 0 SHEET 2 C 2 GLY A 219 THR A 220 -1 O THR A 220 N ASP A 100 SHEET 1 D 2 MET A 106 LEU A 108 0 SHEET 2 D 2 LYS A 214 TYR A 216 -1 O LYS A 214 N LEU A 108 SHEET 1 E 4 GLU A 133 GLY A 135 0 SHEET 2 E 4 TYR A 185 GLU A 190 1 O LEU A 188 N GLY A 135 SHEET 3 E 4 ILE A 110 ARG A 115 -1 N LEU A 113 O LEU A 187 SHEET 4 E 4 LEU A 204 ILE A 207 -1 O THR A 205 N TYR A 114 SHEET 1 F 3 TYR B 51 LEU B 55 0 SHEET 2 F 3 LEU B 6 THR B 10 1 N VAL B 8 O LYS B 54 SHEET 3 F 3 LEU B 84 ALA B 85 1 O LEU B 84 N THR B 9 SHEET 1 G 2 MET B 18 TYR B 19 0 SHEET 2 G 2 PHE B 32 GLU B 33 -1 O GLU B 33 N MET B 18 SHEET 1 H 2 ASP B 100 PHE B 101 0 SHEET 2 H 2 GLY B 219 THR B 220 -1 O THR B 220 N ASP B 100 SHEET 1 I 2 MET B 106 LEU B 108 0 SHEET 2 I 2 LYS B 214 TYR B 216 -1 O LYS B 214 N LEU B 108 SHEET 1 J 4 GLU B 133 GLY B 135 0 SHEET 2 J 4 TYR B 185 GLU B 190 1 O LEU B 188 N GLY B 135 SHEET 3 J 4 ILE B 110 ARG B 115 -1 N SER B 111 O MET B 189 SHEET 4 J 4 LEU B 204 ILE B 207 -1 O THR B 205 N TYR B 114 SSBOND 1 CYS A 202 CYS A 256 1555 1555 2.04 SSBOND 2 CYS B 202 CYS B 256 1555 1555 2.06 CISPEP 1 GLU A 14 PRO A 15 0 -3.57 CISPEP 2 GLU B 14 PRO B 15 0 -1.70 SITE 1 AC1 16 GLU A 13 TYR A 16 TYR A 61 PRO A 88 SITE 2 AC1 16 LEU A 89 THR A 90 ARG A 95 SER A 141 SITE 3 AC1 16 THR A 142 SER A 173 GLU A 190 SER A 193 SITE 4 AC1 16 TYR A 216 HOH A 401 HOH A 565 HOH A 573 SITE 1 AC2 4 LYS A 103 HOH A 581 LYS B 103 HOH B 470 SITE 1 AC3 18 GLU B 13 TYR B 16 TYR B 61 PRO B 88 SITE 2 AC3 18 LEU B 89 THR B 90 ARG B 95 GLY B 140 SITE 3 AC3 18 SER B 141 THR B 142 SER B 173 MET B 189 SITE 4 AC3 18 GLU B 190 SER B 193 TYR B 216 HOH B 427 SITE 5 AC3 18 HOH B 476 HOH B 478 SITE 1 AC4 4 GLN A 165 ARG B 20 LYS B 24 ARG B 81 SITE 1 AC5 7 ARG A 31 LYS A 54 HOH A 430 HOH A 473 SITE 2 AC5 7 HOH A 576 GLU B 133 ARG B 179 CRYST1 69.320 69.320 234.970 90.00 90.00 90.00 P 41 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014426 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014426 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004256 0.00000